1. Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment
    Guodong Liao et al, 2021, Frontiers in Oncology CrossRef
  2. New perspectives in the treatment of patients with intermediate-2 and high-risk myelodysplastic syndrome
    E. V. Morozova et al, 2022, Oncohematology CrossRef
  3. The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer
    Inna M. Yasinska et al, 2019, Frontiers in Immunology CrossRef
  4. Overexpression of LAG3, TIM3, and A2aR in adenoid cystic carcinoma and mucoepidermoid carcinoma
    Meng‐Jie Zhang et al, 2023, Oral Diseases CrossRef
  5. Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target
    Minpu Zhang et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
  6. Modulation of the Gal-9/TIM-3 Immune Checkpoint with α-Lactose. Does Anomery of Lactose Matter?
    Christian Bailly et al, 2021, Cancers CrossRef
  7. Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
    Yuanwei Shi et al, 2022, Frontiers in Oncology CrossRef
  8. Prognostic value of T cell immunoglobulin and mucin-domain containing-3 expression in upper gastrointestinal tract tumors: A meta-analysis
    Jing-Jing Yan et al, 2023, World Journal of Gastrointestinal Oncology CrossRef
  9. Identification of PDCD1 and PDCD1LG2 as Prognostic Biomarkers and Associated with Immune Infiltration in Hepatocellular Carcinoma
    Wang Li et al, 2022, International Journal of General Medicine CrossRef
  10. The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor
    Jared Becerril-Rico et al, 2021, Stem Cell Research & Therapy CrossRef
  11. Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis
    Danzan Mansorunov et al, 2021, Diagnostics CrossRef
  12. Norepinephrine Enhances Aerobic Glycolysis and May Act as a Predictive Factor for Immunotherapy in Gastric Cancer
    Yangyang Wang et al, 2021, Journal of Immunology Research CrossRef

  13. The Association Between Immune Characteristic and Clinical Pathology in Chinese Patients with Adenocarcinoma of Esophagogastric Junction


    Yangyang Wang et al, 2020, Cancer Management and Research CrossRef
  14. TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation
    Kui Zang et al, 2021, Frontiers in Oncology CrossRef
  15. Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation
    Shuang Qin et al, 2020, Frontiers in Oncology CrossRef
  16. Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner
    Mikel Etxebeste-Mitxeltorena et al, 2021, Frontiers in Immunology CrossRef